(1)
LEIDEN, Netherlands, April 7, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the filing of its Annual Report on Form 20-F for the year ended 31 December 2020 with the U.S. Securities and Exchange Commission (SEC), which is available on the Company s website www.pharming.com under Investors/SEC filings.
About Pharming Group N.V.
Pharming Group N.V. is a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs.
The flagship of our portfolio is our recombinant human C1 esterase inhibitor (rhC1INH) franchise. C1INH is a naturally occurring protein that down regulates the complement cascade in order to control inflammation in affected tissues.
Intravacc announces positive preclinical data for its SARS-CoV-2 nose spray vaccine
notimerica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from notimerica.com Daily Mail and Mail on Sunday newspapers.
Intravacc announces positive preclinical data for its SARS-CoV-2 nose spray vaccine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM
LEIDEN, The Netherlands, April 6, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the publication of its Annual Report for the year ended 31 December 2020, which is available on the Company s website www.pharming.com under Investors/Financial Documents.
In addition, the Company s 2021 Annual General Meeting (AGM) will be held at 16:00CET on Wednesday, 19 May 2021. The Notice to Convene, Explanatory Notes, meeting documents and Form of Proxy can be found on the Company s website, www.pharming.com under Investors/Shareholders Meetings.